Bausch + Lomb to launch VICTUS Femtosecond Laser Platform for cataract surgery

Overview Femtosecond Laser / Cataract Surgery

Source: www.news-medical.net/news/20110914/Bausch-2b-Lomb-to-launch-VICTUS-Femtosecond-Laser-Platform-for-cataract-surgery.aspx

Bausch + Lomb to launch VICTUS Femtosecond Laser Platform for cataract surgery

Published on September 14, 2011

Bausch + Lomb, the global leader in eye health, and Technolas™ Perfect Vision GmbH (TPV), a leading ophthalmology laser company, plan to introduce the VICTUS™ Femtosecond Laser Platform at the upcoming XXIX Congress of the European Society of Cataract and Refractive Surgeons (ESCRS 2011). The VICTUS platform is a first-of-its-kind technology, capable of supporting cataract, refractive and therapeutic procedures in a single platform. The versatile platform is designed to enable greater precision compared to manual cataract surgery techniques, potentially enhancing the patient experience.

"I believe the femtosecond laser is the single most significant advancement in cataract surgery in the last 40 years," said Stephen G. Slade, MD, FACS with Slade & Baker Vision Center. "The introduction of the latest femtosecond laser, the VICTUS platform, by these two industry leaders further validates the field of laser cataract surgery. Bringing laser technology to cataract surgery will benefit both surgeons and our patients."

Bausch + Lomb and TPV are currently working with regulatory authorities around the world to secure marketing approvals for the new platform and, as previously announced, will promote the system globally, leveraging their combined cataract and refractive expertise and commercial capabilities.

"Our focus is on bringing innovative products, like the VICTUS platform, to market that uniquely benefit ophthalmic surgeons and patients," said Robert E. Grant, chief executive officer and president, Global Surgical Business, for Bausch + Lomb. "TPV's advanced German engineering and precise manufacturing are perfect complements to Bausch + Lomb's substantial surgical product portfolio and commercial expertise as a global eye health leader."